The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together for the common goal, say 2 MIT researchers
It’s a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.
An essential new way to move discoveries forward has emerged in the form of multi-stakeholder collaborations involving three or more different types of organizations, such as drug companies, government regulators and patient groups, write Magdalini Papadaki, a research associate, and Gigi Hirsch, a physician-entrepreneur and executive director of the MIT Center for Biomedical Innovation.
The authors are calling for a new “science of collaboration” to learn what works and doesn’t work; to improve how leaders can design, manage and evaluate collaborations; and to help educate and train future leaders with the necessary organizational and managerial skills.
“Getting new, better, affordable drugs to the right patients faster involves a series of historically independent decisions made by different players or stakeholders,” says Hirsch. The system is uncoordinated, takes too long, and costs too much. In some cases, the drug—such as new antibiotics for life-threatening resistant infections—may never become available.
“One of the interesting paradoxes of biomedical innovation is increasingly going to be that even though we have the scientific knowledge required to provide potentially better treatments for patients—or even to prevent disease in those who are at high risk—we may be unable to help patients benefit from them anytime soon,” she says.
To help change this scenario, in the last decade, thousands of researchers, pharmaceutical and biotechnology companies, government regulators, payers, clinicians and patients have come together in more than 100 multi-stakeholder collaborations to solve some specific shared problem standing in the way of finding a cure or a better diagnostic approach.
“Multi-stakeholder collaborations provide the opportunity to create an environment that allows for new kinds of interactions among the players,” Hirsch says. The largest multi-stakeholder effort, the European Union’s Innovative Medicines Initiative (IMI) began in 2008 and has established more than 40 consortia with financial and in-kind investments totaling €2 billion. Some projects focus on specific health issues, such as Alzheimer’s disease, chronic pain, diabetes and obesity. Others tackle bigger issues, such as drug and vaccine safety and the use of stem cells for drug discovery. The success has led to a proposal to extend the effort for 10 years and €3.5 billion. Last year, the U.S. President’s Council of Advisors on Science and Technology (PCAST) recommended the U.S. form something similar.
“The prevalence of multi-stakeholder initiatives reflects a continued optimism about the value of this collaboration approach for addressing biomedical innovation bottlenecks,” the authors write in the paper. “Although the need for collaboration is no longer in question, it is worth noting the importance of this development. A willingness to share proprietary data among industry competitors represents a dramatic shift in the culture of the historically highly competitive pharmaceutical industry.”
The article reviews the history of collaborations beginning with HIV/AIDS. By the early 2000s, multi-stakeholder collaborations proliferated to address the need for important tools, such as biomarkers, that require preclinical data sharing. Since then, they have reached to encompass later stages in product development, including manufacturing, reimbursement and post-market monitoring.
Some people involved in multi-stakeholder consortia are concerned about redundancy, inefficiency and lack of productivity of some collaborative efforts, all contributing to a sense of “consortium fatigue,” the researchers write.
In a newer trend, funders and participants are seeking a smaller number of strategically coordinated initiatives that will reliably address critical gaps, Hirsch and Papadaki write. They cite the example of TransCelerate BioPharma, a group of 10 major pharmaceutical companies that came together to share and direct resources toward selected priorities in order to improve the efficiency of drug development, such as clinical trial site qualification standards.
The authors propose a rigorous evidence-based approach (the science of collaboration) to figure out what works and doesn’t work in collaborations. They recommend early steps in this new field and structuring the research to help learn from the past but also to evolve effectively as new innovation challenges emerge.
The Latest Bing News on:
Science of collaboration
- College of Western Idaho celebrates Health and Science Building construction progresson April 27, 2024 at 12:56 pm
Nampa, ID (CBS2) — The College of Western Idaho (CWI) has reached an exciting milestone in the construction of the new Health and Science Building.
- Arizona’s pushes space sector’s growth through education, collaboration, economyon April 27, 2024 at 12:00 pm
Our opportunities are boundless, just like space,” Gov. Katie Hobbs told an audience at the second annual Arizona Space Summit in Tempe last month.
- Region to get three new lab schools after state Board of Education approvalon April 26, 2024 at 9:12 pm
The Board of Education has approved six new lab schools, three of which have ties to either Hampton Roads or Western Tidewater. Virginia Gov. Glenn Youngkin has been a champion of lab schools as a way ...
- Takeaways from AP's investigation into fatal police encounters involving injections of sedativeson April 26, 2024 at 9:38 am
An investigation led by The Associated Press has found that the practice of giving sedatives to people detained by police has spread quietly across the nation over the last 15 years, built on question ...
- Harnessing Science-Policy Collaboration: The Vital Role of IPBES Stakeholders in Achieving Global Nature Targetson April 26, 2024 at 12:57 am
COP CBD saw governments worldwide unite behind a set of ambitious targets aimed at addressing biodiversity loss.
- International dairy science collaboration paves the way for tomorrow's resilient dairy herdson April 25, 2024 at 11:41 am
In a new Journal of Dairy Science study, researchers have increased the quantity and quality of the available data on genetic traits related to feed efficiency and methane emissions ...
- The next frontier of forensic science: blood splatter in microgravity?on April 25, 2024 at 2:43 am
Feedback is pleased to see that researchers are looking into the urgent issue of which angle blood might travel at following a violent act in space ...
- The unlikely collaboration rehoming rats bred for science in NZon April 23, 2024 at 9:29 pm
In an unlikely collaboration, Aucklanders seeking to own a pet rat could now help save a life as the NZ Anti-Vivisection Society (NZAVS) launches a new programme to rehome rats bred or used for ...
- Harvard Kennedy School faculty members get creative and collaborative in a new artificial intelligence course moduleon April 23, 2024 at 7:19 am
Since Open AI’s ChatGPT arrived at the end of 2022, generative artificial intelligence has been big news, with many companies scrambling to develop their own tools. The technology is already changing ...
- UChicago scientists tap the power of collaboration to make transformative breakthroughson April 18, 2024 at 5:00 am
Increasingly, scientists are also reaching outside the boundaries of their expertise, collaborating with partners from different disciplines who add their own skills, experience, and perspective to ...
The Latest Google Headlines on:
Science of collaboration
[google_news title=”” keyword=”Science of collaboration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Biomedical innovation
- Biomed Technology Among Pioneering Recipients Of Investment From CUHK Innovation Limited For Microbiome-Based Healthcare Solutionson April 26, 2024 at 4:12 pm
HONG KONG SAR - Media OutReach Newswire - 26 April 2024 - BioMed Technology Holdings Limited ( BioMed ), a start-up founded by CUHK profe ...
- Library Faculty to Help Researchers Access Massive Biomedical Databaseon April 25, 2024 at 11:28 am
UM Libraries received the $40,000 All of Us Academic Libraries Program award. Library faculty Savannah Kelly and Shelby Watson will offer workshops for both beginning and veteran researchers on how to ...
- Advanced cell atlas opens new doors in biomedical researchon April 25, 2024 at 9:15 am
Researchers at Karolinska Institutet have developed a web-based platform that offers an unprecedented view of the human body at the cellular level. The aim is to create an invaluable resource for ...
- Best universities for biomedical science in the UK - A New Scientist Careers Guideon April 23, 2024 at 5:00 pm
Biomedical science is extremely diverse as it encapsulates ... you can select from one of three “employability strands”: medical science in practice, enterprise and innovation, and medical science in ...
- IIT Bombay and BFI partner for healthcare innovation in Indiaon April 22, 2024 at 11:49 am
BFI will invest $900,000 to use IIT Bombay’s expertise in developing technologies to make healthcare more affordable.
- C-CAMP joins the Blockchain for Impact, Biome Virtual Network Programme to propel biomedical innovationon April 22, 2024 at 4:15 am
The Bengaluru-based C-CAMP has a robust pipeline of biomedical innovations in several critical areas such as infectious disease diagnostics, antimicrobial resistance, cell therapy, immuno-oncology, ...
- IKP Knowledge Park partners with BFI to drive advancements in biomedical innovationon April 21, 2024 at 7:39 am
IKP Knowledge Park, a premium Science Park and Incubator in India, on Sunday announced a strategic alliance with Blockchain for Impact (BFI) to join the BFI-Biome Virtual Network Programme.
- C-CAMP Joins Blockchain for Impact, Biome Virtual Network Program to Accelerate Transformative Healthcare Solutions through Biomedical Innovationon April 20, 2024 at 10:32 pm
The partnership between C-CAMP & BFI is looking to support 3 Innovators & 2 Start-ups every year to advance biomedical research & innovation in India.
- Lifecore Biomedical (LFCR) Price Target Decreased by 11.11% to 8.16on April 17, 2024 at 2:44 pm
Lifecore Biomedical Background Information (This description is ... and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Fintel is one of the most ...
- IIT-K And BFI Forge Partnership To Accelerate Healthcare Innovation In Indiaon April 17, 2024 at 1:09 am
The Indian Institute of Technology Kanpur (IIT-K) and Blockchain For Impact (BFI) have announced a strategic partnership, und ...
The Latest Google Headlines on:
Biomedical innovation
[google_news title=”” keyword=”biomedical innovation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]